vaccinia-b7.1 vaccine
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 1999 (NCT00004148)
Timeline
Indications
Mechanism of action
- T-lymphocyte activation antigen CD80Immunity, active
CD80 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vaccinia-b7.1 vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00045227 | Phase 2 | Aug 1, 2002 | National Cancer Institute (NCI) |
| NCT00020254 | Phase 2 | Jun 1, 2000 | National Cancer Institute (NCI) |
| NCT00004148 | Phase 1 | Oct 1, 1999 | National Cancer Institute (NCI), Yeshiva University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 3 | 3 | 2 | 1999 |
| Yeshiva University | Academic/Hospital | 1 | 0 | 1 | 1999 |
2 organizations
Page 1 / 1